Employee Benefit Adviser: Amazon’s PillPack deal a warning shot for PBMs

Employee Benefit Adviser

Amazon’s PillPack deal is continuing to make waves across the health insurance industry. From former pharmacists questioning the quality of patient care Amazon will deliver to determining what level of importance Atul Gawande will set the prescription drug acquisition as the head of Amazon, Berkshire Hathaway and JPMorgan & Chase healthcare venture, this has been important news for the American healthcare arena.

Shandon Fowler, owner and principal of Four8 Insights, a benefits, HR tech and healthcare reform consulting firm in Charleston, S.C., remains vocal about these recent developments in the market. The following is an edited and condensed discussion with Fowler and his thoughts on Amazon’s future in the healthcare and prescription drug market.

Read the full article…